Skip to content

EQA-Programm

Our external quality assessment (EQA) program is aimed at medical laboratories and point-of-care testing sites. The program includes more than 250 clinically relevant external quality assessment schemes and it is compliant with ISO 15189 standard requirements.

Changes in the 2024 program

New schemes and products

  • 2707 Maternal serum screening
  • 8205 Pipette control
  • 5254 Mycoplasma genitalium, drug resistance, nucleic acid detection
  • 5253 Helicobacter pylori, nucleic acid detection
  • 5088 HIV, antibodies and antigen detection, extra set of samples
  • 5231 Mycobacterium tuberculosis, drug resistance, nucleic acid detection, extra set of samples
  • 4389 D-dimer, extra set of samples
  • 5683 Mpox (Monkeypox virus), nucleic acid detection
  • 8850 DNA sequencing (EQUALIS)
  • 8851 Quantification of ABO antibodies (EQUALIS)
  • 8852 Titration of erythrocyte antibodies (EQUALIS)
  • 8853 Iohexol (EQUALIS)
  • 8854 Phosphatidyl ethanol in blood (EQUALIS)
  • 8855 Alcohol biomarkers in urine (EQUALIS)

Planned pilot schemes

Pilot schemes are EQA schemes under our product development.

All changes are listed in the Product Catalogue 2024 on page 5.

Product catalogue 2024

Download the product catalogue from the button below

Aurevia

Subscription for 2024 will open on 2 October 2023

Please subscribe to the 2024 EQA programs before the end of November 2023 to ensure your participation in all needed EQA rounds. You can renew your subscription by contacting our local partner in your country. Direct customers of Labquality can renew their subscriptions on LabScala starting on 2 October 2023. If you need more information, please contact our customer service: info@labquality.fi.

LQ_web news_EQA program 2024_1280x720

Sales and Customer Service

Juha Wahlstedt
Juha Wahlstedt
Sales Director
+358 50 327 5338
Jukka Korhonen
Jukka Korhonen
Key Account Manager
+358 50 540 9351
Minna Kankainen
Minna Kankainen
Customer Service Manager
+358 45 131 1682

Latest news

Read the latest news from the world of quality.

Aurevia appoints Jonna Pelanti as the new Head of EQA business area

We are delighted to announce the appointment of the new Head of the EQA business area Jonna Pelanti.
Meet us at BioMedica in Dublin on 18-20 March.

Meet us at BioMedica in Dublin

Meet us at the BioMedica exhibition at booth A18!

Aurevia appoints Ulrika Hammarström as the new Head of CRO business area

We are delighted to announce the appointment of the new Head of the CRO business area Ulrika Hammarström.
EQA pilot studies in 2025

Introducing the EQA Pilot Studies 2025

Register now for this year's EQA pilot studies! They will be conducted starting in March.

Aurevia appoints Anna-Karin Alm as the new Head of the QA/RA business area

Anna-Karin Alm assumes the QA/RA business area head position in Aurevia and will lead the Aurevia QA/RA organization in...